OUR TEAM
BRIAN ELLIOTT
Principal
With 30 years experience at Senior Management level in the pharma industry, successfully starting, managing and scaling Lifesciences companies in Ireland, Europe and the US. Brian spent 8 years as International Trade Director with Janssen, became Senior VP and CEO Ireland Tibotec-Virco and has since held numerous leadership positions in the biotech industry in Europe and US including several interim C level leadership roles. He currently advises several US-Irish companies and holds a number of Directorship positions in Ireland.
GAVIN CLARK
Partner
Gavin has more than 30 years experience in the industry including commercial positions at Janssen, Bayer, Novartis and Glaxo Wellcome, where he closed a number of significant deals. He was responsible for business development at Tibotec until the acquisition by J&J in 2002. Since 2002, Gavin has provided strategic business development support to biotech companies, as well as held a number of strategic leadership and advisory positions in the industry.
DR. FRANK HEEMSKERK
Partner
After a Bio-medical research background of 15 years at Uni Utrecht (NL), National Institutes of Health (USA) and Uni Pasteur (FR), he has almost 20 years experience in the private sector, starting as Director Research Coordination & Funding for Tibotec-Virco until its acquisition by J&J. He was President of EARMA (the European network of R & I managers in academic and industrial European organizations) and cofounded ProTon Europe (now the largest European association of University Technology Transfer offices). He serves regularly as Expert Evaluator to the European Commission, has been board member of several start-ups, has founded RIMS (BE) and ARC Innoventures (India).
COLIN EDWARDS
Partner
With over 30 years of experience in the pharmaceutical industry, most recently as General Manager and Head of Medical Affairs for Boehringer Ingelheim in Ireland, Colin brings a depth of clinical and medical experience to Procela’s clients. Colin has personally designed, directed and led successful multinational clinical trials across the EU. Colin holds a PhD in Biochemistry from University of London and a Bsc of Biochemistry from University College Dublin. He currently serves as an advisor to companies in the lifesciences industry.
DR. ROGER FRECHETTE
Partner
As a leading figure in the New England life sciences community, Roger has been building, leading and mentoring biotech companies for nearly twenty years. Roger was previously US East Coast Ambassador for Medicon Valley Alliance, and Co-Founder of Frontiera Therapeutics. As an early sponsor for the North Shore InnoVentures biotech incubator, Roger served as a mentor and advisor to the Incubator management team. Previously, he was Co-Founder of MaxThera, an antibacterial drug discovery company, sold in 2010 to Biota Holdings Limited. Prior to starting MaxThera, Dr. Frechette led multidisciplinary drug discovery teams and chemistry departments at companies such as Paratek Pharmaceuticals and RiboGene, and also managed international strategic partnerships. He began his career as a medicinal chemist at the R.W. Johnson Pharmaceutical Research Institute. In his spare time, he serves on steering committees for a number well-regarded Boston area conferences and associations. Roger was a Post-Doctoral Fellow at Yale University, earned his PhD in Organic Chemistry from Wesleyan University and his BA in Chemistry from College of the Holy Cross.
KEVIN ELLIOTT
Partner
With over a decade spent advising US companies on the challenges and opportunities associated with internationalization, Kevin has advised a number of North American biopharma and medical device companies on issues associated with IP planning, and operational and strategic planning for growth and development in Europe. Kevin is a former Council Member on international trade at Gerson Lehrman Group, the leading network of global experts, and has provided his expertise to a number of top educational institutions including Yale University. Leading the West Coast operations of Procela, Kevin’s clients in the pharma industry have ranged from several of the top 10 players, to a number of specialty pharma as well as clinical stage and startup biotech ventures. With previous experience in management consulting, the public sector and at global institutions such as the UN, Kevin has a Bachelor in Business Studies from Trinity College Dublin, and a Msc in International Business Administration from Copenhagen Business School.
BARRY ELLIOTT
Partner - Nutrition & Supplements
Barry is a chartered physiotherapist and has a Masters in Business and Entrepreneurship. Barry has clinical healthcare experience and has also significantly contributed to projects for the WHO in the area of Healthcare expenditure and analysis.
Barry has led a number of Procela research projects and reporting in the last three years and has run his own successful business in healthcare.
In addition to our core team above, Procela works with a network of leading experts from across the US and Europe as needed on a case-by-case basis.
OUR CORE AREAS OF FOCUS
BIOTECH AND PHARMACEUTICALS
MEDICAL DEVICES & DIAGNOSTICS
NUTRITION & SUPPLEMENTS
WHO WE ARE
Procela brings together a small group of highly successful life sciences executives to offer a full service partnership to grow and develop your life sciences business internationally.
Procela’s experienced team of executives have a proven track record in successfully founding, scaling and commercializing life sciences companies in the US, Europe and Internationally.
WHAT WE DO
Procela offers a full suite of services that enable life sciences companies to access funding and to grow their business in Europe and the US. Our team of experienced executives have a highly successful track record at global biopharma and medical device companies, as well as a number of successful startup and clinical stage biotech companies.
Leveraging this wealth of knowledge and experience, we assist clinical stage and speciality biopharma and medical device companies from North America to secure appropriate and tailored funding and to gain a foothold in the European marketplace, as well as facilitating European companies to launch in the US market.
OUR SERVICES INCLUDE
-
Fundraising & Investment
-
EU & US business and market entry specialists
-
Build-up of footprint in Europe/US
-
Strategic Business Development & Licensing
-
Clinical & Regulatory Affairs
-
R&D Grant Funding Access
-
Intellectual Property Planning and Tax Optimization
-
On-the-ground Substance to meet tax and regulatory requirements
-
Corporate Services & Directorships
-
Strategic Planning
-
Start-up office and administration services
-
Management and scaling of all resources in new markets
Life Sciences Internationalization
Global Licensing & Business Development
Tailored Fundraising & Investment
International Operations
European & US Market Access
Boston - Brussels - California - Dublin - Geneva - London
